Vima LLC’s Pfizer PFE Stock Holding History

Vima LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-200	Closed	-$8.16K	–	275
2024 Q1	$8.16K	Hold	200	–	–	0.01%	254
2023 Q4	$5.76K	Buy	+200	New	+$6.05K	0.01%	292

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vima LLC's PFE Position: Q2 2024 in Review

Vima LLC sold out of Pfizer (PFE) in Q2 2024, closing a stake of 200 shares — an estimated $8.16K sold.

Vima LLC first reported a position in PFE in Q4 2023 and held it in 2 quarters. The position peaked at $8.16K in Q1 2024. 2,874 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

Vima LLC reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
Vima LLC sold 200 Pfizer shares in Q2 2024, an estimated $8.16K.
Vima LLC first reported a position in Pfizer in Q4 2023 and held it in 2 quarters.
Vima LLC's Pfizer position peaked at $8.16K in Q1 2024.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Vima LLC's 13F filing for Q2 2024, filed 8 Aug 2024.